ASSIGNMENT OF LEASEAssignment of Lease • May 24th, 2023 • Tcr2 Therapeutics Inc. • Biological products, (no disgnostic substances)
Contract Type FiledMay 24th, 2023 Company IndustryTHIS ASSIGNMENT OF LEASE (this “Assignment”) is made as of May 23, 2023 but effective as of June 1, 2023 (“Effective Date”) is made by and between TCR2 THERAPEUTICS INC., a Delaware corporation (“TCR2”), and ASTRAZENECA PHARMACEUTICALS LP, a Delaware limited partnership (“AstraZeneca”).